Anti‐cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjögren's syndrome

Por Sène, D, Ghillani‐Dalbin, P, Limal, N, Thibault, V, van Boekel, T, Piette, J‐C, Cacoub, P
Publicado em 2006

Anti-C1q antibodies in hepatitis C virus infection

Por Saadoun, D, Sadallah, S, Trendelenburg, M, Limal, N, Sene, D, Piette, J C, Schifferli, J A, Cacoub, P
Publicado em 2006

Expansion of autoreactive unresponsive CD21(-/low) B cells in Sjögren's syndrome associated lymphoproliferation

Por Saadoun, D, Terrier, B, Bannock, J, Vazquez, T, Massad, C, Kang, I, Joly, F, Rosenzwajg, M, Sene, D, Benech, P, Klatzmann, D, Meffre, E, Cacoub, P
Publicado no Arthritis Rheum (2013)

Management of chronic hepatitis C in French departments of internal medicine and infectious diseases.

Por Cacoub, P., Goderel, I., Morlat, P., Sene, D., Myers, R. P., Alric, L., Loustaud-Ratti, V., Melin, P., Limal, N., Ouzan, D., Perronne, C., Carrat, F.
Publicado em 2005

Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study

Por Sène, D., Pol, S., Piroth, L., Goujard, C., Dellamonica, P., Moussali, J., Rey, D., Loustaud-Ratti, V., Alric, L., Chousterman, M., Borsa-Lebas, F., Boucher, O., Séréni, D., Cacoub, P.
Publicado em 2007